Metilfenidato (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Metilfenidato" in Italian language version.

refsWebsite

Global rank Italian rank

32nih.gov

4^th place

9^th place

10doi.org

2^nd place

7^th place

9oadoi.org

799^th place

22^nd place

4archive.org

6^th place

8^th place

3web.archive.org

1^st place

2agenziafarmaco.gov.it

low place

1,603^rd place

1mentalhealth.com

low place

1google.it

215^th place

4^th place

1psychiatryonline.org

4,032^nd place

3,374^th place

1nice.org.uk

3,258^th place

8,692^nd place

1incb.org

low place

1pittsburghlive.com

4,802^nd place

low place

1repubblica.it

78^th place

2^nd place

1liebertonline.com

low place

agenziafarmaco.gov.it

Disturbo da Deficit di Attenzione con Iperattività (ADHD): le tappe per un uso razionale dei farmaci (PDF), su agenziafarmaco.gov.it, vol. 13, n. 5, Bollettino Informazione sui Farmaci, 2006, 197-203. URL consultato il 18 giugno 2013.
Il metilfenidato nella terapia del disturbo da deficit di attenzione con iperattività nell'età evolutiva (PDF), su agenziafarmaco.gov.it, vol. 6, n. 6, Bollettino di Informazione sui farmaci, 2001, 232-236. URL consultato il 18 giugno 2013.

archive.org

ND. Volkow, GJ. Wang; JS. Fowler; SJ. Gatley; J. Logan; YS. Ding; R. Hitzemann; N. Pappas, Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate., in Am J Psychiatry, vol. 155, n. 10, ottobre 1998, pp. 1325-31, PMID 9766762.
J. Biederman, J. Newcorn; S. Sprich, Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders., in Am J Psychiatry, vol. 148, n. 5, Mag 1991, pp. 564-77, PMID 2018156.
A. Schteinschnaider, LL. Plaghos; S. Garbugino; D. Riveros; A. Lazarowski; S. Intruvini; M. Massaro, Cerebral arteritis following methylphenidate use., in J Child Neurol, vol. 15, n. 4, aprile 2000, pp. 265-7, PMID 10805196.
M. Tan, R. Appleton, Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy., in Arch Dis Child, vol. 90, n. 1, gennaio 2005, pp. 57-9, DOI:10.1136/adc.2003.048504, PMID 15613514.

doi.org

dx.doi.org

C. Davis, L. Fattore; AS. Kaplan; JC. Carter; RD. Levitan; JL. Kennedy, The suppression of appetite and food consumption by methylphenidate: the moderating effects of gender and weight status in healthy adults., in Int J Neuropsychopharmacol, vol. 15, n. 2, marzo 2012, pp. 181-7, DOI:10.1017/S1461145711001039, PMID 21733284.
GS. Goldfield, C. Lorello; J. Cameron; JP. Chaput, Gender differences in the effects of methylphenidate on energy intake in young adults: a preliminary study., in Appl Physiol Nutr Metab, vol. 36, n. 6, dicembre 2011, pp. 1009-13, DOI:10.1139/h11-098, PMID 22029641.
K. Chakraborty, S. Grover, Methylphenidate-induced mania-like symptoms., in Indian J Pharmacol, vol. 43, n. 1, febbraio 2011, pp. 80-1, DOI:10.4103/0253-7613.75678, PMID 21455430.
EC. Fettahoglu, A. Satilmis; C. Gokcen; E. Ozatalay, Oral megadose methylphenidate ingestion for suicide attempt., in Pediatr Int, vol. 51, n. 6, dicembre 2009, pp. 844-5, DOI:10.1111/j.1442-200X.2009.02929.x, PMID 20158630.
SH. Lee, WS. Seo; HM. Sung; TY. Choi; SY. Kim; SJ. Choi; BH. Koo; JH. Lee, Effect of methylphenidate on sleep parameters in children with ADHD., in Psychiatry Investig, vol. 9, n. 4, Dic 2012, pp. 384-90, DOI:10.4306/pi.2012.9.4.384, PMID 23251204.
G. Thomalla, T. Kucinski; C. Weiller; J. Röther, Cerebral vasculitis following oral methylphenidate intake in an adult: a case report., in World J Biol Psychiatry, vol. 7, n. 1, 2006, pp. 56-8, DOI:10.1080/15622970510029966, PMID 16428221.
SA. Tavakoli, OC. Gleason, Seizures associated with venlafaxine, methylphenidate, and zolpidem., in Psychosomatics, vol. 44, n. 3, pp. 262-4, DOI:10.1176/appi.psy.44.3.262, PMID 12724513.
M. Schertz, T. Steinberg, Seizures induced by the combination treatment of methylphenidate and sertraline., in J Child Adolesc Psychopharmacol, vol. 18, n. 3, Giu 2008, pp. 301-3, DOI:10.1089/cap.2007.0141, PMID 18582188.
M. Tan, R. Appleton, Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy., in Arch Dis Child, vol. 90, n. 1, gennaio 2005, pp. 57-9, DOI:10.1136/adc.2003.048504, PMID 15613514.
H. Zhang, M. Du; S. Zhuang, Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD., in Neuropediatrics, vol. 41, n. 2, Ago 2010, pp. 55-9, DOI:10.1055/s-0030-1261893, PMID 20799150.

google.it

books.google.it

P.R. Breggin, Talking Back To Ritalin: What Doctors Aren't Telling You About Stimulants, su books.google.it, Cambridge, De Capo Press, 2001, p. 32. URL consultato il 20 marzo 2016.

incb.org

Green List: Annex to the annual statistical report on psychotropic substances (form P) Archiviato il 31 agosto 2012 in Internet Archive. 23rd edition. August 2003. International Narcotics Board, Vienna International Centre. Accessed 02 March 2006

liebertonline.com

Mannuzza, S., Klein, R.G., Moulton, J.L. (2003). "Does Stimulant Treatment Place Children at Risk for Adult Substance Abuse? A Controlled, Prospective Follow-up Study". Journal of Child and Adolescent Psychopharmacology, Sep 2003, Vol. 13, No. 3: 273-282.

mentalhealth.com

Internet Mental Health

nice.org.uk

National Institute for Health and Clinical Excellence, 2008, disponibile on line http://www.nice.org.uk/nicemedia Archiviato il 20 ottobre 2012 in Internet Archive. /pdf/CG72NiceGuidelinev3.pdf

nih.gov

ncbi.nlm.nih.gov

N.D. Volkow e J.M. Swanson, Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD (PDF), in Am J Psychiatry, vol. 160, n. 11, novembre 2003, pp. 1909-1918, PMID 14594733. URL consultato il 20 marzo 2016.
WA Morton e GG Stockton, Methylphenidate Abuse and Psychiatric Side Effects, in Prim Care Companion J Clin Psychiatry, vol. 2, n. 2, ottobre 2000, pp. 159–164. URL consultato il 20 marzo 2016.
VR. Anderson e Scott LJ., Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children., in Drugs, vol. 66, n. 8, 2006, pp. 1117-26, PMID 16789796.
ND. Volkow, GJ. Wang; JS. Fowler; SJ. Gatley; J. Logan; YS. Ding; R. Hitzemann; N. Pappas, Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate., in Am J Psychiatry, vol. 155, n. 10, ottobre 1998, pp. 1325-31, PMID 9766762.
ND. Volkow, JS. Fowler; GJ. Wang; YS. Ding; SJ. Gatley, Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies., in Eur Neuropsychopharmacol, vol. 12, n. 6, dicembre 2002, pp. 557-66, PMID 12468018.
C. Davis, L. Fattore; AS. Kaplan; JC. Carter; RD. Levitan; JL. Kennedy, The suppression of appetite and food consumption by methylphenidate: the moderating effects of gender and weight status in healthy adults., in Int J Neuropsychopharmacol, vol. 15, n. 2, marzo 2012, pp. 181-7, DOI:10.1017/S1461145711001039, PMID 21733284.
GS. Goldfield, C. Lorello; J. Cameron; JP. Chaput, Gender differences in the effects of methylphenidate on energy intake in young adults: a preliminary study., in Appl Physiol Nutr Metab, vol. 36, n. 6, dicembre 2011, pp. 1009-13, DOI:10.1139/h11-098, PMID 22029641.
WJ. Barbaresi, SK. Katusic; RC. Colligan; AL. Weaver; CL. Leibson; SJ. Jacobsen, Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study., in J Dev Behav Pediatr, vol. 27, n. 1, febbraio 2006, pp. 1-10, PMID 16511362.
MB. Denckla, JR. Bemporad; MC. MacKay, Tics following methylphenidate administration. A report of 20 cases., in JAMA, vol. 235, n. 13, marzo 1976, pp. 1349-51, PMID 1061848.
MA. Pollack, NL. Cohen; AJ. Friedhoff, Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy., in Arch Neurol, vol. 34, n. 10, ottobre 1977, pp. 630-2, PMID 269683.
KD. Gadow, E. Nolan; J. Sprafkin; J. Sverd, School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment., in J Dev Behav Pediatr, vol. 16, n. 3, giugno 1995, pp. 167-76, PMID 7560119.
K. Chakraborty, S. Grover, Methylphenidate-induced mania-like symptoms., in Indian J Pharmacol, vol. 43, n. 1, febbraio 2011, pp. 80-1, DOI:10.4103/0253-7613.75678, PMID 21455430.
EC. Fettahoglu, A. Satilmis; C. Gokcen; E. Ozatalay, Oral megadose methylphenidate ingestion for suicide attempt., in Pediatr Int, vol. 51, n. 6, dicembre 2009, pp. 844-5, DOI:10.1111/j.1442-200X.2009.02929.x, PMID 20158630.
J. Biederman, J. Newcorn; S. Sprich, Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders., in Am J Psychiatry, vol. 148, n. 5, Mag 1991, pp. 564-77, PMID 2018156.
SR. Pliszka, Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview., in J Clin Psychiatry, 59 Suppl 7, 1998, pp. 50-8, PMID 9680053.
SH. Lee, WS. Seo; HM. Sung; TY. Choi; SY. Kim; SJ. Choi; BH. Koo; JH. Lee, Effect of methylphenidate on sleep parameters in children with ADHD., in Psychiatry Investig, vol. 9, n. 4, Dic 2012, pp. 384-90, DOI:10.4306/pi.2012.9.4.384, PMID 23251204.
RB. Sangal, J. Owens; AJ. Allen; V. Sutton; K. Schuh; D. Kelsey, Effects of atomoxetine and methylphenidate on sleep in children with ADHD., in Sleep, vol. 29, n. 12, Dic 2006, pp. 1573-85, PMID 17252888.
G. Thomalla, T. Kucinski; C. Weiller; J. Röther, Cerebral vasculitis following oral methylphenidate intake in an adult: a case report., in World J Biol Psychiatry, vol. 7, n. 1, 2006, pp. 56-8, DOI:10.1080/15622970510029966, PMID 16428221.
A. Schteinschnaider, LL. Plaghos; S. Garbugino; D. Riveros; A. Lazarowski; S. Intruvini; M. Massaro, Cerebral arteritis following methylphenidate use., in J Child Neurol, vol. 15, n. 4, aprile 2000, pp. 265-7, PMID 10805196.
JM. Trugman, Cerebral arteritis and oral methylphenidate., in Lancet, vol. 1, n. 8585, marzo 1988, pp. 584-5, PMID 2894511.
SA. Tavakoli, OC. Gleason, Seizures associated with venlafaxine, methylphenidate, and zolpidem., in Psychosomatics, vol. 44, n. 3, pp. 262-4, DOI:10.1176/appi.psy.44.3.262, PMID 12724513.
M. Schertz, T. Steinberg, Seizures induced by the combination treatment of methylphenidate and sertraline., in J Child Adolesc Psychopharmacol, vol. 18, n. 3, Giu 2008, pp. 301-3, DOI:10.1089/cap.2007.0141, PMID 18582188.
M. Tan, R. Appleton, Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy., in Arch Dis Child, vol. 90, n. 1, gennaio 2005, pp. 57-9, DOI:10.1136/adc.2003.048504, PMID 15613514.
R. Arcieri, EA. Germinario; M. Bonati; G. Masi; A. Zuddas; S. Vella; F. Chiarotti; P. Panei, Cardiovascular measures in children and adolescents with attention-deficit/hyperactivity disorder who are new users of methylphenidate and atomoxetine., in J Child Adolesc Psychopharmacol, vol. 22, n. 6, dicembre 2012, pp. 423-431, PMID 23362511.
H. Zhang, M. Du; S. Zhuang, Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD., in Neuropediatrics, vol. 41, n. 2, Ago 2010, pp. 55-9, DOI:10.1055/s-0030-1261893, PMID 20799150.
Tiihonen J., et al. (2006). "A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence".
Jensen, Peter S., Lori Kettle, Margaret T. Roper, Michael T. Sloan, Mina K. Dulcan, Christina Hoven, Hector R. Bird, Jose J. Bauermeister, and Jennifer D. Payne. 1999. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. Journal of the American Academy of Child and Adolescent Psychiatry 38 (7):797-804.
Adriani, W. et al. (2005). "metilfenidato Administration to Adolescent Rats Determines Plastic Changes on Reward-Related Behavior and Striatal Gene Expression". Neuropsychopharmacology advance online publication 23 November 2005;doi:10.1038/sj.npp.1300962.
Wilens, T., et al. (2005). ADHD treatment with once-daily OROS metilfenidato: final results from a long-term open-label study". J Am Acad Child Adolesc Psychiatry. 2005 Oct;44(10):1015-23.
Rao J.K., Julius J.R., Breen T.J., Blethen S.L. (1996). "Response to growth hormone in attention deficit hyperactivity disorder: effects of metilfenidato and pemoline therapy". Pediatrics. 1998 Aug;102(2 Pt 3):497-500.
Spencer, T.J., et al. (1996). "Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?". J Am Acad Child Adolesc Psychiatry. 1996 Nov;35(11):1460-9.
Klein R.G. & Mannuzza S. (1988). "Hyperactive boys almost grown up. III. metilfenidato effects on ultimate height". Arch Gen Psychiatry. 1988 Dec;45(12):1131-4.

oadoi.org

C. Davis, L. Fattore; AS. Kaplan; JC. Carter; RD. Levitan; JL. Kennedy, The suppression of appetite and food consumption by methylphenidate: the moderating effects of gender and weight status in healthy adults., in Int J Neuropsychopharmacol, vol. 15, n. 2, marzo 2012, pp. 181-7, DOI:10.1017/S1461145711001039, PMID 21733284.
GS. Goldfield, C. Lorello; J. Cameron; JP. Chaput, Gender differences in the effects of methylphenidate on energy intake in young adults: a preliminary study., in Appl Physiol Nutr Metab, vol. 36, n. 6, dicembre 2011, pp. 1009-13, DOI:10.1139/h11-098, PMID 22029641.
K. Chakraborty, S. Grover, Methylphenidate-induced mania-like symptoms., in Indian J Pharmacol, vol. 43, n. 1, febbraio 2011, pp. 80-1, DOI:10.4103/0253-7613.75678, PMID 21455430.
EC. Fettahoglu, A. Satilmis; C. Gokcen; E. Ozatalay, Oral megadose methylphenidate ingestion for suicide attempt., in Pediatr Int, vol. 51, n. 6, dicembre 2009, pp. 844-5, DOI:10.1111/j.1442-200X.2009.02929.x, PMID 20158630.
SH. Lee, WS. Seo; HM. Sung; TY. Choi; SY. Kim; SJ. Choi; BH. Koo; JH. Lee, Effect of methylphenidate on sleep parameters in children with ADHD., in Psychiatry Investig, vol. 9, n. 4, Dic 2012, pp. 384-90, DOI:10.4306/pi.2012.9.4.384, PMID 23251204.
G. Thomalla, T. Kucinski; C. Weiller; J. Röther, Cerebral vasculitis following oral methylphenidate intake in an adult: a case report., in World J Biol Psychiatry, vol. 7, n. 1, 2006, pp. 56-8, DOI:10.1080/15622970510029966, PMID 16428221.
SA. Tavakoli, OC. Gleason, Seizures associated with venlafaxine, methylphenidate, and zolpidem., in Psychosomatics, vol. 44, n. 3, pp. 262-4, DOI:10.1176/appi.psy.44.3.262, PMID 12724513.
M. Schertz, T. Steinberg, Seizures induced by the combination treatment of methylphenidate and sertraline., in J Child Adolesc Psychopharmacol, vol. 18, n. 3, Giu 2008, pp. 301-3, DOI:10.1089/cap.2007.0141, PMID 18582188.
H. Zhang, M. Du; S. Zhuang, Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD., in Neuropediatrics, vol. 41, n. 2, Ago 2010, pp. 55-9, DOI:10.1055/s-0030-1261893, PMID 20799150.

pittsburghlive.com

Pittsburgh Tribune-Review. "More students abusing hyperactivity drugs Archiviato il 23 dicembre 2005 in Internet Archive.".

psychiatryonline.org

ajp.psychiatryonline.org

N.D. Volkow e J.M. Swanson, Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD (PDF), in Am J Psychiatry, vol. 160, n. 11, novembre 2003, pp. 1909-1918, PMID 14594733. URL consultato il 20 marzo 2016.

repubblica.it

«Sostanze psicotrope per lavorare le usa uno scienziato su cinque», La Repubblica.it, 11 aprile 2008

web.archive.org

National Institute for Health and Clinical Excellence, 2008, disponibile on line http://www.nice.org.uk/nicemedia Archiviato il 20 ottobre 2012 in Internet Archive. /pdf/CG72NiceGuidelinev3.pdf
Green List: Annex to the annual statistical report on psychotropic substances (form P) Archiviato il 31 agosto 2012 in Internet Archive. 23rd edition. August 2003. International Narcotics Board, Vienna International Centre. Accessed 02 March 2006
Pittsburgh Tribune-Review. "More students abusing hyperactivity drugs Archiviato il 23 dicembre 2005 in Internet Archive.".